Notably, the irisin concentrations in patients with chronic cardiovascular disease are stable (Panagiotou et al., 2014), whereas the irisin concentrations decrease gradually in saliva and serum within 48 h after acute myocardial infarction (AMI; Aydin et al., 2014). This evidence concerns the gene FNDC5 and myocardial infarction.